Literature DB >> 10537193

Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.

B Favre1, M Didmon, N S Ryder.   

Abstract

Lanosterol 14alpha-demethylase (14DM) is the target of the azole antifungals, and alteration of the 14DM sequence leading to a decreased affinity of the enzyme for azoles is one of several potential mechanisms for resistance to these drugs in Candida albicans. In order to identify such alterations the authors investigated a collection of 19 C. albicans clinical isolates demonstrating either frank resistance (MICs > or = 32 microg ml(-1)) or dose-dependent resistance (MICs 8-16 microg ml(-1)) to fluconazole. In cell-free extracts from four isolates, including the Darlington strain ATCC 64124, sensitivity of sterol biosynthesis to inhibition by fluconazole was greatly reduced, suggesting that alterations in the activity or affinity of the 14DM could contribute to resistance. Cloning and sequencing of the 14DM gene from these isolates revealed 12 different alterations (two to four per isolate) leading to changes in the deduced amino acid sequence. Five of these mutations have not previously been reported. To demonstrate that these alterations could affect fungal susceptibility to azoles, the 14DM genes from one sensitive and three resistant C. albicans strains were tagged at the carboxyl terminus with a c-myc epitope and expressed in Saccharomyces cerevisiae under control of the endogenous promoter. Transformants receiving 14DM genes from resistant strains had fluconazole MICs up to 32-fold higher than those of transformants receiving 14DM from a sensitive strain, although Western blot analysis indicated that the level of expressed 14DM was similar in all transformants. Amino acid substitutions in the 14DM gene from the Darlington strain also conferred a strong cross-resistance to ketoconazole. In conclusion, multiple genetic alterations in C. albicans 14DM, including several not previously reported, can affect the affinity of the enzyme for azoles and contribute to resistance of clinical isolates.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537193     DOI: 10.1099/00221287-145-10-2715

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  30 in total

1.  Amphiphilic Tobramycin Analogues as Antibacterial and Antifungal Agents.

Authors:  Sanjib K Shrestha; Marina Y Fosso; Keith D Green; Sylvie Garneau-Tsodikova
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

Review 2.  The development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen.

Authors:  Joachim Morschhäuser
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

3.  Evaluation of the V404I and V509M amino acid substitutions of ERG11 gene in Candida albicans isolates by pyrosequencing.

Authors:  T-H Kim; M-K Lee
Journal:  Folia Microbiol (Praha)       Date:  2010-06-06       Impact factor: 2.099

4.  A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.

Authors:  E Mellado; G Garcia-Effron; L Alcázar-Fuoli; W J G Melchers; P E Verweij; M Cuenca-Estrella; J L Rodríguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

5.  Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.

Authors:  S Perea; J L López-Ribot; W R Kirkpatrick; R K McAtee; R A Santillán; M Martínez; D Calabrese; D Sanglard; T F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

6.  Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.

Authors:  Li-Hua Yu; Xin Wei; Ming Ma; Xiao-Jun Chen; Shuang-Bo Xu
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

7.  Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.

Authors:  Brunella Posteraro; Rosa Martucci; Marilena La Sorda; Barbara Fiori; Dominique Sanglard; Elena De Carolis; Ada Rita Florio; Giovanni Fadda; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

8.  The cytochrome P450 lanosterol 14alpha-demethylase gene is a demethylation inhibitor fungicide resistance determinant in Monilinia fructicola field isolates from Georgia.

Authors:  Chao-Xi Luo; Guido Schnabel
Journal:  Appl Environ Microbiol       Date:  2007-11-16       Impact factor: 4.792

9.  Molecular mechanisms of itraconazole resistance in Candida dubliniensis.

Authors:  Emmanuelle Pinjon; Gary P Moran; Colin J Jackson; Steven L Kelly; Dominique Sanglard; David C Coleman; Derek J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

10.  Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.

Authors:  Huiping Wang; Fanrong Kong; Tania C Sorrell; Bin Wang; Paul McNicholas; Namfon Pantarat; David Ellis; Meng Xiao; Fred Widmer; Sharon Ca Chen
Journal:  BMC Microbiol       Date:  2009-08-14       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.